The Effect of Biologics in the Treatment of Multisystem Inflammatory Syndrome in Children (Mis-C): A Single-Center Propensity-Score-Matched Study
Multisystem inflammatory syndrome in children (MIS-C) is a serious condition characterized by excessive inflammation that can arise as a complication of SARS-CoV-2 infection in children. While our understanding of COVID-19 and MIS-C has been advancing, there is still uncertainty regarding the optima...
Main Authors: | Ozge Basaran, Ezgi Deniz Batu, Ummusen Kaya Akca, Erdal Atalay, Muserref Kasap Cuceoglu, Seher Sener, Zeynep Balık, Erdem Karabulut, Selman Kesici, Tevfik Karagoz, Yasemin Ozsurekci, Yelda Bilginer, Ali Bulent Cengiz, Seza Ozen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-06-01
|
Series: | Children |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9067/10/6/1045 |
Similar Items
-
MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN: DIAGNOSTIC MARKERS AND FEATURES OF PHARMACOTHERAPY
by: M.V. Кhaitovych, et al.
Published: (2021-03-01) -
Multisystem inflammatory syndrome in adults - In COVID-19
by: Vasantha Kamath, et al.
Published: (2023-01-01) -
Multisystemic Inflammatory Syndrome Temporally Associated with COVID-19 in a Regional Pediatric Hospital from México
by: Joel Barroso-Santos, et al.
Published: (2023-05-01) -
The Role of Lung Ultrasound in Diagnosing COVID-19-Related Multisystemic Inflammatory Disease: A Preliminary Experience
by: Anna Maria Musolino, et al.
Published: (2022-01-01) -
Nutraceuticals for Complementary Treatment of Multisystem Inflammatory Syndrome in Children: A Perspective from Their Use in COVID-19
by: Diego Estrada-Luna, et al.
Published: (2022-10-01)